Profile data is unavailable for this security.
About the company
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
- Revenue in USD (TTM)58.94m
- Net income in USD15.91m
- Incorporated2013
- Employees92.00
- LocationSemler Scientific Inc2340-2348 Walsh Avenue, Suite 2344SANTA CLARA 95051United StatesUSA
- Phone+1 (408) 627-4557
- Fax+1 (302) 636-5454
- Websitehttps://www.semlerscientific.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | 47.26m | -58.48m | 358.37m | 200.00 | -- | 5.48 | -- | 7.58 | -2.71 | -2.71 | 2.19 | 2.69 | 0.4038 | 0.657 | 6.14 | 236,275.00 | -49.96 | -- | -54.21 | -- | 84.16 | -- | -123.75 | -- | 10.23 | -17.04 | 0.4302 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Nano-X Imaging Ltd | 10.13m | -57.47m | 360.34m | 164.00 | -- | 2.06 | -- | 35.58 | -0.9974 | -0.9974 | 0.1755 | 2.99 | 0.0482 | -- | 6.89 | 61,756.10 | -27.33 | -30.98 | -29.96 | -35.10 | -81.80 | -- | -567.41 | -1,527.24 | 5.09 | -- | 0.0181 | -- | 15.47 | -- | 46.33 | -- | 114.35 | -- |
| MaxCyte Inc | 45.60m | -35.74m | 363.91m | 143.00 | -- | 1.70 | -- | 7.98 | -0.3420 | -0.3420 | 0.4368 | 2.03 | 0.177 | 0.5576 | 7.17 | 318,878.30 | -13.87 | -13.18 | -14.86 | -14.33 | 85.98 | 88.79 | -78.37 | -62.96 | 9.22 | -- | 0.00 | -- | -6.72 | 19.89 | -60.89 | -- | 39.13 | -- |
| ZimVie Inc | 451.30m | -47.73m | 379.21m | 2.60k | -- | 0.9321 | -- | 0.8403 | -1.77 | -13.16 | 16.60 | 14.74 | 0.394 | 1.14 | 4.04 | 173,575.00 | -4.17 | -- | -4.81 | -- | 63.18 | 65.51 | -10.58 | -8.73 | 1.38 | -0.6264 | 0.3514 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
| Tactile Systems Technology Inc | 285.05m | 15.45m | 382.51m | 992.00 | 24.79 | 1.84 | 17.27 | 1.34 | 0.643 | 0.643 | 11.91 | 8.66 | 0.9812 | 6.20 | 6.80 | 287,349.80 | 5.32 | 0.9015 | 6.20 | 1.09 | 51.44 | 49.10 | 5.42 | 0.8309 | 3.80 | -- | 0.1146 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Alpha Teknova Inc | 36.35m | -31.68m | 388.05m | 210.00 | -- | 4.45 | -- | 10.68 | -0.7366 | -0.7366 | 0.834 | 1.64 | 0.2770 | 3.12 | 7.44 | 173,081.00 | -24.14 | -- | -25.92 | -- | 17.71 | -- | -87.17 | -- | 3.94 | -75.86 | 0.133 | -- | -11.43 | -- | 22.52 | -- | -- | -- |
| Quanterix Corp | 129.33m | -39.71m | 449.80m | 441.00 | -- | 1.34 | -- | 3.48 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
| Pacific Biosciences of California Inc | 173.15m | -394.24m | 482.38m | 796.00 | -- | 1.07 | -- | 2.79 | -1.46 | -1.46 | 0.64 | 1.65 | 0.1034 | 1.97 | 5.78 | 217,521.40 | -23.55 | -16.19 | -25.40 | -17.81 | 23.81 | 37.35 | -227.69 | -136.21 | 8.64 | -21.87 | 0.6634 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
| Semler Scientific Inc | 58.94m | 15.91m | 482.70m | 92.00 | 32.42 | 5.54 | 29.16 | 8.19 | 2.05 | 2.05 | 7.58 | 11.99 | 0.6868 | 17.20 | 9.33 | 640,619.60 | 18.54 | 38.83 | 20.37 | 44.41 | 88.05 | 90.22 | 27.00 | 32.58 | 3.09 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Treace Medical Concepts Inc | 202.86m | -61.52m | 494.64m | 516.00 | -- | 4.71 | -- | 2.44 | -0.9924 | -0.9924 | 3.27 | 1.68 | 0.8951 | 1.08 | 8.25 | 393,141.50 | -27.15 | -- | -32.22 | -- | 80.61 | -- | -30.33 | -- | 2.98 | -- | 0.3366 | -- | 31.92 | -- | -15.68 | -- | -- | -- |
| SI-Bone Inc | 157.04m | -37.40m | 515.42m | 344.00 | -- | 3.11 | -- | 3.28 | -0.9108 | -0.9108 | 3.82 | 3.95 | 0.6859 | 1.46 | 7.00 | 456,497.10 | -16.34 | -27.88 | -18.08 | -30.94 | 77.70 | 85.03 | -23.82 | -51.09 | 7.22 | -- | 0.1799 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Mesa Laboratories Inc | 228.38m | -245.65m | 547.81m | 736.00 | -- | 3.39 | -- | 2.40 | -45.57 | -45.57 | 42.13 | 29.79 | 0.4186 | 2.74 | 5.96 | 310,298.90 | -45.02 | -9.20 | -54.70 | -9.88 | 62.47 | 60.60 | -107.56 | -28.33 | 0.5106 | 1.35 | 0.5594 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Surmodics Inc | 126.08m | -11.54m | 559.12m | 389.00 | -- | 4.72 | -- | 4.43 | -0.8145 | -0.8145 | 8.90 | 8.30 | 0.6922 | 2.20 | 6.03 | 324,108.00 | -6.34 | -3.99 | -7.22 | -4.66 | 73.81 | 80.25 | -9.15 | -6.26 | 3.22 | -3.03 | 0.1991 | -- | -4.91 | 4.73 | -651.43 | -- | -12.34 | -- |
| AxoGen Inc | 180.86m | -14.31m | 576.51m | 426.00 | -- | 5.80 | -- | 3.19 | -0.3302 | -0.3302 | 4.16 | 2.26 | 0.9356 | 1.65 | 7.55 | 424,544.60 | -7.40 | -13.92 | -8.49 | -15.84 | 76.13 | 79.74 | -7.91 | -20.28 | 2.47 | -1.50 | 0.3224 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Simulations Plus Inc | 70.01m | 9.95m | 602.82m | 243.00 | 61.38 | 3.30 | 38.60 | 8.61 | 0.4894 | 0.4894 | 3.45 | 9.10 | 0.3659 | -- | 5.55 | 288,119.30 | 5.20 | 6.10 | 5.55 | 6.45 | 61.63 | 74.01 | 14.22 | 18.97 | -- | -- | 0.00 | 45.64 | 17.52 | 15.56 | -0.0703 | 3.01 | 17.07 | 0.00 |
| Standard Biotools Inc | 155.90m | -170.60m | 603.06m | 534.00 | -- | 1.23 | -- | 3.87 | -0.7091 | -0.7091 | 0.5579 | 1.31 | 0.3054 | 2.48 | 6.01 | 291,951.30 | -24.41 | -28.17 | -29.37 | -33.60 | 48.57 | 51.58 | -79.91 | -74.85 | 3.41 | -- | 0.1014 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
Data as of Nov 22 2024. Currency figures normalised to Semler Scientific Inc's reporting currency: US Dollar USD
40.67%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cerity Partners LLCas of 30 Sep 2024 | 1.35m | 19.24% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 342.22k | 4.89% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 302.08k | 4.32% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 169.39k | 2.42% |
| ShariaPortfolio, Inc.as of 30 Sep 2024 | 153.62k | 2.20% |
| Geode Capital Management LLCas of 30 Sep 2024 | 135.96k | 1.94% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 118.22k | 1.69% |
| Jacobs Levy Equity Management, Inc.as of 30 Sep 2024 | 97.74k | 1.40% |
| Renaissance Technologies LLCas of 30 Sep 2024 | 90.43k | 1.29% |
| LPL Financial LLCas of 30 Sep 2024 | 88.33k | 1.26% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
